Treatment and follow-up of children with cerebrotendinous xanthomatosis
暂无分享,去创建一个
[1] A. Tangerman,et al. Chronic diarrhoea as a dominating symptom in two children with cerebrotendinous xanthomatosis , 1996, Acta paediatrica.
[2] J. Cruysberg,et al. Ocular and systemic manifestations of cerebrotendinous xanthomatosis. , 1995, American journal of ophthalmology.
[3] Y. Friedlander,et al. Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics. , 1994, American journal of human genetics.
[4] Y. Tokimura,et al. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use , 1994, Journal of the Neurological Sciences.
[5] A. Korczyn,et al. Magnetic resonance imaging in cerebrotendinous xanthomatosis: A prospective clinical and neuroradiological study , 1994, Journal of the Neurological Sciences.
[6] E. Leitersdorf,et al. Cerebrotendinous xanthomatosis. , 1994, Current Opinion in Lipidology.
[7] J. Cruysberg,et al. Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. , 1991, American journal of ophthalmology.
[8] B. Roitberg,et al. Epileptic Seizure as a Presenting Symptom of Cerebrotendinous Xanthomatosis , 1991, Epilepsia.
[9] Y. Matsuzawa,et al. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. , 1991, Metabolism: clinical and experimental.
[10] Y. Seyama,et al. Cerebrotendinous xanthomatosis: Clinical and biochemical evaluation of eight patients and review of the literature , 1991, Journal of the Neurological Sciences.
[11] J. C. van der Molen,et al. Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. , 1991, Journal of lipid research.
[12] P. Gambert,et al. Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings. , 1991, Neurology.
[13] H. Farpour. Cataracte zonulaire juvénile et Xanthomatose cérébro-tendineuse , 1990 .
[14] H. Farpour. [Zonular juvenile cataract and cerebrotendinous xanthomatosis]. , 1990, Klinische Monatsblatter fur Augenheilkunde.
[15] D. Soffer,et al. Chronic demyelinating peripheral neuropathy in cerebrotendinous xanthomatosis , 1986, Annals of neurology.
[16] J. C. van der Molen,et al. Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[17] C. L. Warner,et al. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid , 1985, Annals of neurology.
[18] S. Shefer,et al. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. , 1984, The New England journal of medicine.
[19] C. Brautbar,et al. Study of a family with Cerebrotendinous Xanthomatosis. No HLA linkage, but an informative recombination between HLA-B and Bf. , 2008, Tissue antigens.
[20] C. Cortese,et al. Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis. , 1983, British medical journal.
[21] J. C. van der Molen,et al. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[22] J. I. Pedersen,et al. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors. , 1981, Journal of lipid research.
[23] A. Korczyn,et al. Peripheral neuropathy in cerebrotendinous xanthomatosis , 1979, Neurology.
[24] H. Farpour,et al. Familial cerebrotendinous xanthomatosis. Report of a new family and review of the literature. , 1975, Archives of neurology.